Weitere kardiovaskul盲re Ereignisse trotz Apherese
详细信息 查看全文
- 作者：Dr. Sergey Tselmin ; Bernd Hohenstein ; Ulrich Julius
- 刊名：CardioVasc
- 出版年：2015
- 出版时间：September 2015
- 年：2015
- 卷：15
- 期：4
- 页码：32-36
- 全文大小：
- 参考文献：1.Armstrong VW, Cremer P, Eberle E et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis. 1986;62(3):249鈥?7.CrossRef PubMed
2.Rhoads GG, Dahlen G, Berg K et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986;256(18):2540鈥?.CrossRef PubMed
3.Dahlen GH, Guyton JR, Attar M et al. Association of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74(4):758鈥?5.CrossRef PubMed
4.Str盲ter R, Becker S, von Eckardstein A et.al. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet. 2002;360(9345):1540鈥?.CrossRef PubMed
5.Dieplinger B, Lingenhel A, Baumgartner N et al. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem. 2007;53(7):1298鈥?05.CrossRef PubMed
6.Kamstrup PR, Tybj忙rg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470鈥?.CrossRef PubMed
7.Tselmin S, Julius U, Mueller G et al. Cardiovascular events in patients with increased lipoprotein(a) - retrospective data analysis in an outpatient department of lipid disorders. Atheroscler Suppl. 2009;10(5):79鈥?4.CrossRef PubMed
8.Schettler VJJ, Roeseler E, Thode C et al. Differenzierung der Indikation zur Lipoproteinapherese bei erh枚htem Lp(a) durch unterschiedliche Messmethoden. Cardiovasc. 2015,15(3):36鈥?8CrossRef
9.Jaeger BR, Richter Y, Nagel D et al. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med. 2009;6(3):229鈥?9.CrossRef PubMed
10.Safarova MS, Ezhov MV, Afanasieva OI et al. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atheroscler Suppl. 2013;14(1):93鈥?9CrossRef PubMed
11.von Dryander M, Fischer S, Passauer J et al. Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern. Atheroscler Suppl. 2013;14(1):39鈥?4.CrossRef
12.Rosada A, Kassner U, Vogt A et al. Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events? Artif Organs. 2014;38(2):135鈥?1.CrossRef PubMed
13.Leebmann J, Roeseler E, Julius U et.al. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation. 2013;128(24):2567鈥?6CrossRef PubMed
14.Taseva K, Fischer S, Passauer J et al. Factors inducing cardiovascular events in patients treated by lipoprotein apheresis. Atheroscler Suppl. 2013;14(1):45鈥?0CrossRef PubMed - 作者单位：Dr. Sergey Tselmin (1)
Bernd Hohenstein (1)
Ulrich Julius (1)
1. Bereich Lipoproteinapherese und extrakorporale Verfahren Medizinische Klinik III, Universit盲tsklinikum Carl Gustav Carus an der Technischen Universit盲t Dresden, Fetscherstra脽e 74, 01307, Dresden, Deutschland - 刊物类别：Cardiology; Internal Medicine; Angiology; Diabetes; Endocrinology;
- 刊物主题：Cardiology; Internal Medicine; Angiology; Diabetes; Endocrinology;
- 出版者：Urban & Vogel
- ISSN：1618-3851
文摘